difamilast 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
phosphodiesterase IV (PDE IV) inhibitors 5503 937782-05-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • difamilast
  • moizerto
  • OPA-15406
  • MM36
Difamilast is a novel atopic dermatitis drug that has phosphodiesterase 4 inhibitory activity. PDE4 inhibitors are believed to improve the symptoms of atopic dermatitis through suppression of the production of chemical mediators such as pro-inflammatory cytokines and through other anti-inflammatory effects.
  • Molecular weight: 446.45
  • Formula: C23H24F2N2O5
  • CLOGP: 4.28
  • LIPINSKI: 0
  • HAC: 7
  • HDO: 1
  • TPSA: 82.82
  • ALOGS: -4.29
  • ROTB: 10

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Sept. 27, 2021 PMDA OTSUKA PHARMACEUTICAL Co., Ltd

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Atopic dermatitis indication 24079001 DOID:3310




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
cAMP-specific 3',5'-cyclic phosphodiesterase 4B Enzyme INHIBITOR IC50 7.95 SCIENTIFIC LITERATURE

External reference:

IDSource
CHEMBL3989968 ChEMBL_ID
C000711049 MESH_SUPPLEMENTAL_RECORD_UI
C119208 MESH_SUPPLEMENTAL_RECORD_UI
9776 IUPHAR_LIGAND_ID
DB14987 DRUGBANK_ID
D11314 KEGG_DRUG
C5139795 UMLSCUI
CHEMBL225555 ChEMBL_ID
10717 INN_ID
57855696 PUBCHEM_CID
T3U32GLJ0F UNII

Pharmaceutical products:

None